Yahoo Finance’s Adam Shapiro speaks with Johnson & Johnson CFO, Joseph Wolk, about the company’s latest earnings report and vaccine outlook. JULIE HYMAN: Shares of Johnson & Johnson are trading ...
The Janssen or Johnson & Johnson COVID-19 vaccine. Image – New York National Guard Poblic Domain U.S. regulators are allowing the release of 10 million doses of Johnson & Johnson’s COVID-19 vaccine ...
Johnson & Johnson said Tuesday that Phase 3 studies show that a booster shot of its COVID-19 vaccine increases protection against moderate cases of the virus to 94% in the U.S. Worldwide, J&J said ...
The U.S. Food and Drug Administration authorized Johnson & Johnson’s Covid vaccine for emergency use in February 2021, nearly a year into the global pandemic that would go on to kill more than one ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results